[go: up one dir, main page]

UY30178A1 - Aril sulfonamidas sustituidas - Google Patents

Aril sulfonamidas sustituidas

Info

Publication number
UY30178A1
UY30178A1 UY30178A UY30178A UY30178A1 UY 30178 A1 UY30178 A1 UY 30178A1 UY 30178 A UY30178 A UY 30178A UY 30178 A UY30178 A UY 30178A UY 30178 A1 UY30178 A1 UY 30178A1
Authority
UY
Uruguay
Prior art keywords
aril
sulfonamides
replaced
arylsulfonamides
prophylaxis
Prior art date
Application number
UY30178A
Other languages
English (en)
Inventor
Tobias Wunberg
Joachim Schuhmacher
Rudolf Schohe-Loop
Bernd Riedl
Daniela Paulsen
Dieter Lang
Kerstin Henninger
Dirk Heimbach
Andreas Goeller
Dagmar Karthaus
Holger Zimmermann
Dr Niels Svenstrup
Original Assignee
Aicuris Gmbh & Amp
Co Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38180640&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UY30178(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Aicuris Gmbh & Amp, Co Kg filed Critical Aicuris Gmbh & Amp
Publication of UY30178A1 publication Critical patent/UY30178A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/73—Unsubstituted amino or imino radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Arilsulfonamidas y procesos para su preparación y su utilización para la producción de medicamentos para el tratamiento y/o la profilaxis de enfermedades, especialmente para su utilización como agentes antivirales, particularmente contra los citomegalovirus.
UY30178A 2006-03-03 2007-02-28 Aril sulfonamidas sustituidas UY30178A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102006009928A DE102006009928A1 (de) 2006-03-03 2006-03-03 Substituierte Arylsulfonamide

Publications (1)

Publication Number Publication Date
UY30178A1 true UY30178A1 (es) 2007-09-28

Family

ID=38180640

Family Applications (1)

Application Number Title Priority Date Filing Date
UY30178A UY30178A1 (es) 2006-03-03 2007-02-28 Aril sulfonamidas sustituidas

Country Status (25)

Country Link
US (1) US8318761B2 (es)
EP (1) EP1991529B1 (es)
JP (1) JP5255455B2 (es)
KR (1) KR101447758B1 (es)
CN (1) CN101389607B (es)
AR (1) AR059710A1 (es)
AT (1) ATE451356T1 (es)
AU (1) AU2007222689B2 (es)
BR (1) BRPI0707068A2 (es)
CA (1) CA2642602C (es)
DE (2) DE102006009928A1 (es)
DK (1) DK1991529T3 (es)
ES (1) ES2335316T3 (es)
IL (1) IL193449A (es)
JO (1) JO2581B1 (es)
MX (1) MX2008011264A (es)
PE (1) PE20080136A1 (es)
PL (1) PL1991529T3 (es)
PT (1) PT1991529E (es)
RU (1) RU2423352C2 (es)
TW (1) TWI388559B (es)
UA (1) UA95103C2 (es)
UY (1) UY30178A1 (es)
WO (1) WO2007101573A1 (es)
ZA (1) ZA200807189B (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10319612A1 (de) 2003-05-02 2004-11-18 Bayer Healthcare Ag Substituierte Dihydrochinazoline
EP2103317A1 (de) * 2008-03-20 2009-09-23 Bayer MaterialScience AG Medizinische Geräte mit hydrophilen Beschichtungen
EP2103316A1 (de) * 2008-03-20 2009-09-23 Bayer MaterialScience AG Hydrophile Polyurethandispersionen
EP2103318A1 (de) * 2008-03-20 2009-09-23 Bayer MaterialScience AG Medizinische Geräte mit hydrophilen Beschichtungen
EP2103638A1 (de) * 2008-03-20 2009-09-23 Bayer MaterialScience AG Hydrophile Polyurethanlösungen
DE102008025613A1 (de) * 2008-05-28 2009-12-03 Bayer Materialscience Ag Hydrophile Polyurethanbeschichtungen
DE102008025614A1 (de) * 2008-05-28 2009-12-03 Bayer Materialscience Ag Hydrophile Polyurethanbeschichtungen
AU2009289831A1 (en) 2008-09-04 2010-03-11 Bayer Materialscience Ag TCD based hydrophilic polyurethane dispersions
DE102011101446A1 (de) * 2011-05-10 2012-11-15 Aicuris Gmbh & Co. Kg Herstellung von "Dense Bodies" (DB)
EP2853532B1 (en) * 2013-09-28 2020-12-09 Instytut Farmakologii Polskiej Akademii Nauk 1,2,4-oxadiazole derivatives as allosteric modulators of metabotropic glutamate receptors belonging to group III
CN109879817B (zh) * 2019-03-19 2020-10-02 扬州大学 甲基二磺隆的制备方法
RU2738848C1 (ru) * 2019-10-24 2020-12-17 Общество с ограниченной ответственностью "Научно-исследовательский институт ХимРар" (ООО "НИИ ХимРар") Ингибитор вируса гепатита В (ВГВ), представляющий собой производные N-{ 3-[6-(диалкиламино)пиридазин-3-ил]фенил} арилсульфонамида и производные N-{ 4-[6-(диалкиламино)пиридазин-3-ил]фенил} арилсульфонамида

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19802437A1 (de) 1998-01-23 1999-07-29 Bayer Ag Verwendung von substituierten Sulfonamiden als anitvirale Mittel und neue Stoffe
US6495578B1 (en) 1999-04-19 2002-12-17 Shionogi & Co., Ltd. Sulfonamide derivatives having oxadiazole rings
DE19920790A1 (de) * 1999-05-06 2000-11-09 Bayer Ag Bis-Sulfonamide mit anti-HCMV-Wirkung
DE19930075A1 (de) 1999-06-30 2001-01-04 Bayer Ag Neue Amino- und Amidosulfonamide als antivirale Mittel
SK12662003A3 (sk) * 2001-04-19 2004-04-06 Bayer Aktiengesellschaft Arylsulfónamidy ako antivírusové činidlá
DE10138578A1 (de) * 2001-08-06 2003-02-27 Bayer Ag Heterocyclylarylsulfonamide

Also Published As

Publication number Publication date
CA2642602C (en) 2014-05-13
IL193449A (en) 2013-02-28
EP1991529B1 (de) 2009-12-09
HK1125371A1 (zh) 2009-08-07
PE20080136A1 (es) 2008-04-18
RU2423352C2 (ru) 2011-07-10
CN101389607A (zh) 2009-03-18
JP2009529016A (ja) 2009-08-13
IL193449A0 (en) 2009-05-04
CA2642602A1 (en) 2007-09-13
RU2008139195A (ru) 2010-04-10
US20090176842A1 (en) 2009-07-09
BRPI0707068A2 (pt) 2011-04-19
WO2007101573A1 (de) 2007-09-13
AR059710A1 (es) 2008-04-23
DE102006009928A1 (de) 2007-09-06
TW200813034A (en) 2008-03-16
CN101389607B (zh) 2011-09-07
PT1991529E (pt) 2010-01-06
DK1991529T3 (da) 2010-04-12
MX2008011264A (es) 2008-09-12
KR101447758B1 (ko) 2014-10-06
EP1991529A1 (de) 2008-11-19
ATE451356T1 (de) 2009-12-15
JP5255455B2 (ja) 2013-08-07
AU2007222689A1 (en) 2007-09-13
DE502007002264D1 (de) 2010-01-21
UA95103C2 (ru) 2011-07-11
ZA200807189B (en) 2009-12-30
AU2007222689B2 (en) 2011-11-17
US8318761B2 (en) 2012-11-27
PL1991529T3 (pl) 2010-05-31
KR20080107456A (ko) 2008-12-10
TWI388559B (zh) 2013-03-11
JO2581B1 (en) 2011-02-27
ES2335316T3 (es) 2010-03-24

Similar Documents

Publication Publication Date Title
UY30178A1 (es) Aril sulfonamidas sustituidas
HN2004000146A (es) Dihidroquinazolinas sustituidas
UY30846A1 (es) Derivados de oxindol sustituidos, medicamentos que los comprenden y uso de los mismos
PA8772101A1 (es) Imidazol-triazolopirimidinas sustituidas
UY31228A1 (es) Ariloxazoles sustituidos y su uso
GT200900230A (es) 4-aril-1,4-dihidro-1,6-naftiridinamidas sustituidas y uso
UY30835A1 (es) 8-alquinilxantinas y derivados
ECSP11011310A (es) Análogos carba - nucleósido para tratamiento antiviral
CR11684A (es) Dihidropirazolonas sustituidas de hif-propil-4- como inhibidores hidroxilasa
DOP2009000165A (es) Derivados de oxindol sustituido, medicamentos que los comprenden y uso de los mismos
UY31133A1 (es) "oxazolidinonas sustituidas y su uso"
ECSP11011483A (es) Piperidinas sustituidas
UY31717A1 (es) (pirazolilcarbonil) imidazolidinonas sustituidas y su uso
UY29416A1 (es) Derivados de ácido pirimidincarboxílico y su uso
CR20110627A (es) Piperidinas sustituidas
UY30135A1 (es) Quinolonas sustituidas iii
UY29189A1 (es) Nonadepsipeptidos acilados ii
ATE380188T1 (de) Substituierte chinolone
UY29264A1 (es) Tiazolidinonas metasustituidas, su preparación y su uso como medicamento
HN2006007774A (es) Imidazoles sustituidos con heterociclilamida
UY29358A1 (es) Tiazolidinonas, su preparacion y su uso como medicamento
CU20080148A7 (es) Quinolonas sustituidas iii
CU23488B7 (es) Dihidroquinazolinas sustituidas con propiedades antivirales
DOP2004000895A (es) Dihidroquinazolinas sustituidas con propiedades antivirales
DOP2009000145A (es) Derivados de 8-etinilxantina como antagonistas de receptores de a2a selectivos

Legal Events

Date Code Title Description
110 Patent granted

Effective date: 20210716